FirstIgnite is supporting the commercialization of Florida International University’s new technology involving silver complexes to treat infections. This technology is effective against drug resistant bacterial strains, attenuates infection without the creation of resistant bacteria or adverse effects, and provides slow release of bioactive silver.
This technology is applicable to creams/patches/bandages to treat burn wounds and other skin infections, the treatment and prevention of infections caused by multidrug resistant Gram-positive, Gram-negative, fungal, and viral infections, and surface treatment of surgical instruments, medical and healthcare devices, and food processing. As of 2022, the global burn care market is worth $2.4 billion and is expected to grow to $4.2 billion by 2030.
Florida International University’s new technology involving silver complexes to treat infections is ready for commercialization, and they are looking for industry feedback on their research and potential future collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.